Broken String Bioscience’s technology platform, INDUCE-seq®, supports the development of cell and gene therapies that are safer by design. INDUCE-seq®, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs.
| Website | http://www.brokenstringbio.com |
| Employees | 35 (24 on RocketReach) |
| Address | Chesterford Research Park, Suite 8, Sidney Sussex Building, Little Chesterford, England CB10 1XL, GB |
| Industry | Biotechnology Research |
| Keywords | Cell Therapies, Gene Therapies, Ngs, Dna Sequencing, Next Generation Sequencing, Platform Technology, Genome Editing, Gene Editing, Cell Engineering, Genetic Engineering, Molecular Diagnostics, Therapeutics, Research Tools, Precision Medicine, Biotechnology, Drug Discovery, Biopharmaceutical, Cancer Research, Rare Disease Research |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, QIAGEN, 10x Genomics, Twist Bioscience, PacBio, Bionano Genomics, Inc., Genomatix AG +47 more (view full list) |
Looking for a particular Broken String Biosciences employee's phone or email?
Broken String Biosciences Questions
Simon Reed is the Co-founder and CSO, of Broken String Biosciences.
24 people are employed at Broken String Biosciences.
Broken String Biosciences is based in Little Chesterford, England.
Top Broken String Biosciences Employees
-
21
-
Felix Dobbs
Co-Founder & CEO at Broken String Biosciences
United Kingdom1 -
Samantha MacRo
CFO at Broken String Biosciences
Cambridge, Cambridgeshire, United Kingdom51 -
55+
-
Simon Kerr
Chair & COO at Broken String Biosciences
Cambridge, GB21
Related Companies
